Rebopag 50 Mg

Rebopag 50 Mg (Eltrombopag)

Price range: $300.00 through $500.00

Active Ingredient (Generic Name) Eltrombopag
Indication Low platelet count due to ITP or HCV infection
Manufacturer MSN Laboratories
Packaging 7 tablets in 1 strip
Strength 50mg
Delivery Time 6 to 15 Days
SKU: N/A Categories: ,

Rebopag 50 mg, containing Eltrombopag, is used to treat low platelet counts related to ITP and HCV infection. It effectively enhances platelet production to help reduce bleeding risks.

Rebopag 50 Mg (Eltrombopag) - Tablet

Tablet Price Price/unit Quantity Add to cart
28 Tablet/s $300 $10.71 per Tablet
56 Tablet/s $500 $8.93 per Tablet

What is Rebopag 50 mg?

Rebopag 50 mg is a prescription medication commonly used to treat low platelet counts, particularly in individuals suffering from immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection-related thrombocytopenia. Its active ingredient, Eltrombopag, plays a crucial role in stimulating platelet production, helping patients maintain a healthier blood profile.

Manufactured by MSN Laboratories, Rebopag 50 mg is trusted by healthcare professionals for its effectiveness in managing conditions associated with reduced platelet levels. If you are in Canada and looking for reliable options to support your platelet counts, understanding how Rebopag 50 mg works and its potential benefits is essential.

Uses of Rebopag 50 mg

  • Treatment of low platelet counts in adults with immune thrombocytopenia (ITP).
  • Managing thrombocytopenia in patients with chronic hepatitis C virus (HCV) infection to allow interferon-based therapy.
  • As prescribed by healthcare providers to improve platelet levels when standard treatments are ineffective or unsuitable.
  • Patients undergoing colorectal cancer therapy such as Regonat 40 Mg may also need platelet monitoring and support

How Rebopag 50 mg Works

Eltrombopag, the key ingredient in Rebopag 50 mg, is a thrombopoietin receptor agonist. It binds to and activates the thrombopoietin receptor, which stimulates the production of platelets in the bone marrow. By enhancing megakaryocyte maturation—the cells responsible for producing platelets—this medication helps increase platelet count, reducing risks associated with bleeding and bruising.

This mechanism makes Rebopag 50 mg an important option for patients who experience platelet deficiencies due to autoimmune responses or viral infections. It supports the body’s natural processes rather than merely controlling symptoms.

Benefits of Rebopag 50 mg

  • Effective platelet increase: Helps raise platelet counts in patients with ITP or HCV-related thrombocytopenia.
  • Oral administration: Taken as a convenient oral tablet, facilitating easy incorporation into daily routines.
  • Improved quality of life: Reduces bleeding risks, leading to better overall health and fewer hospital visits.
  • Supports therapy continuation: Enables HCV patients to continue necessary antiviral treatments that might otherwise be stopped due to low platelet counts.
  • Manufactured with quality: Produced by MSN Laboratories, ensuring compliance with safety and effectiveness standards.
  • \n

  • Also available as Rebopag 25 Mg for patients needing a lower strength

Dosage and Administration

The typical dosage of Rebopag 50 mg varies based on the individual’s medical condition and response to treatment. It is generally prescribed as a daily oral tablet, with the exact dose adjusted by your healthcare provider.

It is important to take Rebopag 50 mg exactly as prescribed, swallowing the tablet whole with water. Consistent timing of doses helps maintain steady medication levels in the bloodstream.

Regular blood tests will be required to monitor platelet counts and adjust dosage accordingly. Always consult your doctor before changing any medication administration or dose.

Who Should Use Rebopag 50 mg?

Rebopag 50 mg is suitable for adults diagnosed with low platelet counts due to:

  • Immune thrombocytopenia (ITP), especially when other treatments have proven insufficient.
  • Chronic hepatitis C virus (HCV) infection leading to thrombocytopenia, allowing antiviral therapies to continue safely.
  • Cases where boosting platelet count is crucial to avoid bleeding complications.

Who Should Avoid Rebopag 50 mg?

Certain individuals should exercise caution or avoid Rebopag 50 mg, including those:

  • With known hypersensitivity to eltrombopag or any ingredients in the formulation.
  • Experiencing liver problems that have not been evaluated by a healthcare professional.
  • With a history of blood clots, as the medication may increase clotting risk.
  • Pregnant or breastfeeding women unless advised by a doctor, since safety is not fully established in these groups.

Side Effects

  • Common side effects: Headache, nausea, fatigue, and mild abdominal discomfort.
  • Liver enzyme elevations: Periodic liver function tests are recommended as eltrombopag can impact liver health.
  • Risk of blood clots: Though rare, some patients may develop thrombosis, so any unusual swelling or pain, especially in legs or chest, should be reported immediately.
  • Allergic reactions: Symptoms such as rash, itching, or swelling require urgent medical attention.
  • Bleeding or bruising: Paradoxical bleeding may occur if platelet counts do not improve sufficiently.

Safety Advice

  • Always inform your doctor about your full medical history before starting Rebopag 50 mg.
  • Do not adjust dosage or discontinue treatment without consulting a healthcare professional.
  • Undergo regular blood tests to monitor platelet levels and liver function.
  • Report any side effects promptly, especially signs of liver issues or blood clots.
  • Avoid sharing medication and keep it out of reach of children.
  • Inform your doctor of all other medications or supplements you are taking to avoid interactions.

Drug Interactions

  • Concurrent use with antacids, dairy products, or supplements containing calcium should be spaced out from eltrombopag doses to avoid reduced absorption.
  • Careful monitoring if taken alongside blood thinners or other medications affecting platelet function.
  • Potential interactions with antiviral drugs used for HCV, which require medical supervision.

Storage Instructions

Store Rebopag 50 mg tablets at room temperature, away from moisture, heat, and direct sunlight. Keep the medication in its original packaging until use and ensure it is out of reach of children and pets. Do not use expired medicine and dispose of it responsibly following local regulations.

Where to buy Rebopag 50 mg in UK?

If you are considering where to buy Rebopag 50 mg in UK, it is essential to obtain this medication through licensed pharmacies or authorized online platforms. Always ensure a valid prescription from your healthcare provider before purchasing. Licensed Canadian pharmacies also supply Rebopag 50 mg with professional guidance, ensuring safety and authenticity.

Frequently Asked Questions (FAQ)

How long does it take for Rebopag 50 mg to start working?

Patients typically begin to see an increase in platelet counts within 1 to 2 weeks of starting treatment, though response time can vary based on individual health and condition severity.

What should I do if Rebopag 50 mg does not work?

If you don’t notice improvement, consult your doctor. Dosage adjustments or alternative therapies might be necessary to manage your condition effectively.

What is the price of Rebopag 50 mg in UK?

The cost can vary depending on the pharmacy and prescription plan. It is advisable to check with local licensed pharmacies or reputable online sources for competitive pricing.

Is Rebopag 50 mg safe for older adults?

Older adults can use Rebopag, but with careful monitoring due to potential age-related liver or other health considerations. Always discuss risks and benefits with your healthcare provider.

What happens if I miss a dose?

Take the missed dose as soon as you remember unless it is near the time for your next dose. Never double the dose to make up for a missed one.

Can side effects from Rebopag 50 mg be prevented?

While not all side effects are preventable, following dosing instructions carefully and attending regular medical check-ups significantly decreases risks.

Is it safe to use Rebopag 50 mg daily?

Yes, daily use is standard when prescribed, but it must be under strict medical supervision to monitor platelet levels and liver health.

Conclusion

Rebopag 50 mg offers an effective and convenient treatment option for patients dealing with low platelet counts caused by immune thrombocytopenia or HCV infection. With its active ingredient eltrombopag, this medication supports platelet production, helping to reduce bleeding risks and improve quality of life. For individuals in Canada seeking to Buy Rebopag 50 mg, understanding its uses, benefits, and safety considerations is vital to ensure the best treatment outcomes. Always consult a healthcare professional for personalized advice and proper monitoring throughout your therapy.